Skip to main content

Table 2 Multivariable models of OS and PFS adjusted to prognostic factors

From: Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer

Biomarkers HR (95% CI), n  = 50

Multivariable model of OS

P

Multivariable model of PFS

P

PBLC (prior to ICIs)

0.280(0.095–0.823)

0.021

0.413(0.141–1.213)

0.108

Adjusted PBLC (prior to ICIs)

0.482(0.233–0.999)

0.049

0.693(0.337–1.426)

0.319

PBLC (post treatment)

0.459(0.148–1.422)

0.177

0.791(0.285–2.422)

0.681

NLR

1.150(1.052–1.257)

0.002

1.086(1.002–1.177)

0.045

Adjusted NLR

2.575(1.217–5.447)

0.013

2.189(1.085–4.414)

0.029

MLR

3.880(0.665–22.626)

0.132

3.433(0.610-19.327)

0.162

Adjusted MLR

1.802(0.858–3.787)

0.120

1.619(0.802–3.271)

0.179

PLR

1.004(1.000-1.008)

0.028

1.002(0.999–1.006)

0.161

Adjusted PLR

1.596(0.714–3.568)

0.255

1.596(0.709–3.593)

0.259

ICIs lines

1.929(1.289–2.887)

0.001

2.778(1.819–4.241)

0.00

Age

1.007(0.959–1.057)

0.784

1.075(1.011–1.143)

0.021

  1. 1. Age, HER-2 expression, and number of treatment lines and liver metastases were adjusted in PBLC, MLR and PLR multivariable models. 2. Age, HER-2 expression, and treatment lines were adjusted in NLR multivariable model. 3. Age, HER-2 expression, and liver metastasis were adjusted in ICIs lines multivariable models. 4. HER-2 expression, number of treatment lines, liver metastasis were adjusted in Age multivariable model